4//SEC Filing
Dahl Andrew M. 4
Accession 0001225208-25-004946
CIK 0001099800other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:34 PM ET
Size
7.5 KB
Accession
0001225208-25-004946
Insider Transaction Report
Form 4
Dahl Andrew M.
SVP, Corporate Controller
Transactions
- Award
Common Stock
2025-05-08+3,335→ 8,106.527 total - Award
Employee Stock Option (Right to Acquire)
2025-05-08+5,670→ 5,670 totalExercise: $74.63From: 2026-05-08Exp: 2032-05-07→ Common Stock (5,670 underlying)
Footnotes (2)
- [F1]These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0002022347
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:34 PM ET
- Size
- 7.5 KB